Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 708 participants.
Also called NCT01778049
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 708 participants
- Registry
-
NCT01778049 -
2012-002271-34
-
- Other papers using this trial's data
- Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russia, Spain, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT01778049. Randomized; double masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-03 (actual). Results posted on 2016-04-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- BI 10773 Placebo
- Intervention (Drug)
- BI 10773 / BI 1356
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- BI 10773 / BI 1356
- Intervention (Drug)
- BI 10773 / BI 1356 Placebo
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- BI 10773 / BI 1356 Placebo
- Intervention (Drug)
- BI 10773 Placebo
- Intervention (Drug)
- BI 10773 / BI 1356 Placebo
- Intervention (Drug)
- BI 10773
- Intervention (Drug)
- BI 10773 / BI 1356 Placebo
- Lead sponsor
- Boehringer Ingelheim
- Collaborator
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01778049- Content hash
8c2604fca733485ec4a5a82c029cf13e810e5d1de2741c8a79efcb48bcd76440